BEMPEGALDESLEUKIN vs BENRALIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BEMPEGALDESLEUKIN vs BENRALIZUMAB: Safety Overview
| Metric | BEMPEGALDESLEUKIN | BENRALIZUMAB |
|---|---|---|
| Total FAERS Reports | 174 | 15,738 |
| Deaths Reported | 22 | 1,618 |
| Death Rate | 12.6% | 10.3% |
| Hospitalizations | 159 | 3,707 |
| Average Patient Age | 64.9 yrs | 59.1 yrs |
| % Female Patients | 23.6% | 69.4% |
| Manufacturer | N/A | AstraZeneca Pharmaceuticals LP |
| Route | N/A | SUBCUTANEOUS |
| Marketing Status | N/A | Prescription |